Related Experiment Videos
3D-biohybrid systems: applications in drug screening
Alexandra Reininger-Mack1, Hagen Thielecke, Andrea A Robitzki
1Fraunhofer Institute for Biomedical Engineering (FhG-IBMT), Department of Biohybrid Systems, Ensheimer Str. 48, 66386 St Ingbert/Saar, Germany.
Trends in Biotechnology
|January 30, 2002
Summary
Biohybrid sensors utilize 3D tissue aggregates for rapid drug testing and therapy monitoring. This innovative approach enhances functional characterization of molecular changes in tissues.
Area of Science:
- Biotechnology
- Bioengineering
- Tissue Engineering
Background:
- Cellular biosensors monitor molecular alterations in tissues.
- Existing biosensors offer insights into cellular transduction pathways.
- Advanced methods are needed for functional characterization and monitoring.
Purpose of the Study:
- To describe recent biosensor systems.
- To discuss the use of 3D tissue aggregates as recognition elements.
- To present an innovative biohybrid sensor for drug testing.
Main Methods:
- Utilizing 3D heart muscle and tumor tissue aggregates.
- Positioning tissue models in capillary systems.
- Employing electrical potential recording and impedance measurement.
Main Results:
- Demonstrated effectiveness of biohybrid sensors for drug testing.
- Enabled rapid monitoring of drug and therapy effectiveness.
- Showcased potential for functional characterization of tissue responses.
Conclusions:
- 3D tissue aggregates are effective recognition elements in biohybrid sensors.
- Biohybrid sensors offer a rapid and efficient platform for drug efficacy testing.
- This technology advances molecular monitoring in biotechnology applications.